U.S. Consumer Durables Stock News

Colgate-Palmolive recently announced a four-year collaboration with the WHO Foundation to fund initiatives that expand oral health education, integrate oral care into national health systems, and elevate oral health as a public health priority worldwide. This partnership underscores how corporate funding can influence global health policy and further embed oral care within broader primary healthcare agendas. Next, we’ll examine how Colgate-Palmolive’s long-term WHO Foundation partnership,...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Recent share performance and business snapshot NVR (NVR) has drawn attention after a 3.5% move over the past day and a 5.4% gain over the past month, prompting investors to reassess the homebuilder’s recent performance and valuation. The company operates across Homebuilding and Mortgage Banking, with US$10.6b in revenue and US$1.4b in net income, while annual revenue and net income both show single digit percentage declines year over year. Short term returns are mixed, with a 2.8% gain over...

Why nVent Electric is on investors’ radar nVent Electric (NVT) has drawn fresh attention after a solid run in the stock, with recent returns over the past month and past 3 months standing out against its longer multi year track record. See our latest analysis for nVent Electric. The recent 7 day share price return of 7.77% and 30 day share price return of 9.60% add to an 11.97% 90 day gain. A 1 year total shareholder return of 50.65% and very large 5 year total shareholder return suggest...

ONEOK (OKE) just announced a 4% increase in its quarterly dividend to US$1.07 per share, or US$4.28 annually, a move many income focused investors watch closely. See our latest analysis for ONEOK. The dividend news arrives as ONEOK’s share price sits at US$75.82, with a 90 day share price return of 8.69% and a 5 year total shareholder return of 150.24%, suggesting long term momentum despite a 1 year total shareholder return decline of 24.92%. If this dividend move has you thinking about other...

Extreme Networks (EXTR) is drawing fresh interest after launching its Extreme Partner First program in January 2026, a global framework that simplifies rebates, deal registration, pricing transparency, and AI supported sales tools for channel partners. See our latest analysis for Extreme Networks. The Extreme Partner First launch comes after a tougher stretch for the shares, with a 30 day share price return of an 11.07% decline and a 90 day share price return of a 28.52% decline, while the 5...

In recent months, large institutional traders have engaged in 17 unusual options transactions on American Airlines Group across strikes ranging from US$10 to US$25, while the company’s short interest has fallen to about 6% of its tradable shares, below the peer average. This combination of mixed options positioning by financial institutions and a meaningful reduction in short interest has sharpened market focus on American Airlines’ upcoming earnings announcement. Next, we’ll explore how...

Impinj, Inc. recently announced a licensing agreement with EM Microelectronic to integrate its Gen2X technology into future dual-frequency RFID endpoint ICs, which EM expects to bring to market in 2027. This partnership extends Impinj’s technology into another chipmaker’s roadmap, potentially broadening its role within the RFID ecosystem and deepening its influence on next-generation tag designs. Next, we’ll examine how this Gen2X licensing deal with EM Microelectronic shapes Impinj’s...

Investors may be wondering if Reynolds Consumer Products, at around US$24.28 a share, still offers solid value or if most of the opportunity is already reflected in the price. Over the short term, the stock has been fairly steady, with a 0.2% decline over 7 days, a 3.1% gain over 30 days, and a 5.3% return year to date. The 1 year return sits at an 8.7% decline, and the 3 and 5 year returns are 8.2% and 8.9% declines respectively. Recent attention on household and consumer staples companies...

If you are wondering whether Uranium Energy's share price really lines up with its underlying value, this article will walk through what the current numbers actually suggest. The stock last closed at US$18.82, with returns of 9.5% over 7 days, 50.8% over 30 days, 43.6% year to date and 138.2% over 1 year, while the 3 year return is 376.5% and the 5 year figure is very large. These moves sit against an ongoing stream of sector and company specific news that keeps uranium names in focus,...

If you are trying to figure out whether Carvana's current share price lines up with its underlying value, this article will walk through the key numbers and what they might mean for you. Carvana last closed at US$455.02, with a 7 day return of a 0.8% decline, a 30 day return of 4.9%, a year to date return of 13.7% and a 1 year return of 94.4%. The 3 year return is very large at around 70 times, and the 5 year return is 90.1%. Recent coverage around Carvana has focused on its business model,...

Textron Inc. recently drew fresh investor attention as its aerospace and defense operations gained recognition among analysts, while its E-Z-GO subsidiary unveiled the redesigned 2027 Liberty personal transportation vehicle featuring advanced infotainment, diagnostics, and street‑legal low‑speed capability planned for dealer availability from summer 2026. This combination of momentum in defense and a tech‑enhanced E-Z-GO lineup highlights Textron’s breadth across military, aviation, and...

Why the East Edge launch matters for Norfolk Southern stock Norfolk Southern (NSC) has launched its East Edge double-stack intermodal corridor between Chicago and New England, a major infrastructure upgrade that shortens rail transit times and lifts capacity through Ayer, Massachusetts. See our latest analysis for Norfolk Southern. Norfolk Southern’s recent news has come alongside a 3.11% 1 day share price return and a 1.86% 90 day share price return, while the 1 year total shareholder return...

In recent weeks, multiple Wall Street firms have reiterated positive views on HubSpot, highlighting a solid 2026 deal pipeline and a supportive backdrop for software companies. Options activity shows large investors taking both bullish and bearish positions around a wide range of potential outcomes, underscoring how divisive expectations for HubSpot’s longer-term trajectory have become. Next, we’ll examine how this analyst optimism around HubSpot’s 2026 deal pipeline shapes the company’s...

Recent commentary on Robert Half Inc highlights its long-running, steadily rising dividend and a debt-free balance sheet that underpins those shareholder payouts, even as sales and earnings have softened in the current economic backdrop. An interesting angle for investors is the combination of this dividend history with strong financial soundness scores, which points to considerable balance-sheet flexibility despite recent operational pressures. Next, we will explore how this focus on...

Glendale and Long Beach win adds to Verra Mobility’s California footprint Verra Mobility (VRRM) has been tapped by Glendale and Long Beach to deliver, operate, and maintain speed safety programs under California’s Assembly Bill 645 pilot. This extends its role in automated traffic enforcement across the state. See our latest analysis for Verra Mobility. Despite winning new California contracts, Verra Mobility’s recent share price momentum has been soft, with a 90 day share price return of...

In January 2026, ADMA Biologics raised its preliminary unaudited revenue guidance for 2025 to about US$510 million–US$511 million and lifted its 2026 outlook to roughly US$635 million, while also issuing new longer-term targets. The company now projects revenue of about US$775 million for 2027 and more than US$1.10 billion for 2029, giving investors an extended view of its growth ambitions. Next, we’ll explore how this expanded multi-year revenue guidance shapes ADMA Biologics’ investment...

In recent days, Henry Schein, Inc. announced the upcoming appointment of Thermo Fisher veteran Frederick M. Lowery as CEO in March 2026 and secured exclusive U.S. distribution rights for CytoChip’s FDA 510(k)-cleared, CLIA-waived CitoCBC system in ambulatory and critical access hospital settings. Together, this leadership change and point-of-care diagnostics agreement highlight Henry Schein’s push to pair experienced operational leadership with differentiated, higher-value medical...

Leadership shift and AI focus at DigitalOcean Holdings (DOCN) DigitalOcean Holdings (DOCN) has appointed Vinay Kumar as Chief Product and Technology Officer, tasking him with steering product strategy, cloud infrastructure, and security as the company scales its AI inference and core cloud offerings. See our latest analysis for DigitalOcean Holdings. The leadership change comes on the heels of product news in AI inference, and the stock’s recent moves reflect that mix of execution and...

Murphy Oil (NYSE:MUR) reported that its Civette-1X exploration well offshore Côte d'Ivoire encountered non-commercial hydrocarbons. The result, in Block CI-502, was announced as an early-stage outcome that will inform the company's international exploration efforts. Murphy Oil plans to focus next on the nearby Caracal and Bubale prospects in the same offshore area. Murphy Oil, an independent exploration and production company, is using this early result from Civette-1X as a data point for...

Trip.com Group recently disclosed that it received a notice of investigation from China’s State Administration for Market Regulation under the Anti-Monopoly Law, prompting multiple U.S. law firms to launch shareholder-focused probes into potential securities law and business practice issues. This convergence of regulatory scrutiny in China and legal investigations in the U.S. raises important questions about Trip.com’s operating model and risk profile. Next, we’ll examine how this...

ServisFirst Bancshares (SFBS) capped FY 2025 with fourth quarter revenue of US$154.3 million and EPS of US$1.58, as trailing twelve month figures reached US$527.1 million in revenue and EPS of US$5.06. Over the past year, revenue has moved from US$458.7 million on a trailing basis to US$527.1 million, while EPS over the same period shifted from US$4.17 to US$5.06, providing additional context for how you might think about the bank’s earnings power. With a trailing net profit margin of 52.5%...

Align Technology (NasdaqGS:ALGN) has launched commercial Invisalign treatment in Thailand, expanding its clear aligner offering into a new Asia Pacific market. The rollout introduces Align’s flagship product to Thai dental professionals and patients, adding another country to the company’s international footprint. Multiple recent analyst rating and target price updates highlight shifting views on Align’s prospects following this product expansion. Align Technology, the company behind...

Charles Schwab FY 2025 Earnings Snapshot Charles Schwab (SCHW) closed FY 2025 with fourth quarter revenue of US$6.3 billion and basic EPS of US$1.34, alongside net income excluding extra items of US$2.4 billion, putting a solid set of headline numbers in front of investors. The company has seen quarterly revenue move from US$5.3 billion and EPS of US$0.94 in Q4 2024 to US$6.3 billion and EPS of US$1.34 in Q4 2025, alongside trailing twelve month EPS of US$4.67 and revenue of US$24.0 billion...